In 1982, two Australian physician-scientists discovered a spiral-shaped bacterium whose form not only dictated function, but its capacity to dwell in the human body's harshest chemical environment. These two clues would help ...
The Netherlands Cancer Institute has found that the estrous cycle stage significantly influences mammary tumors' sensitivity to chemotherapy. In mouse models of breast cancer, treatment initiated during the diestrus stage ...
New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new insights ...
May 9, 2025
0
58
Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG have announced promising outcomes from a Phase II clinical trial of a novel cancer immunotherapy, ...
May 9, 2025
0
27
Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm called "FaceAge" that uses ...
May 8, 2025
0
31
Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other approaches that attack pancreatic ...
May 8, 2025
0
2
Colorectal cancer is the third most diagnosed type of cancer worldwide. Up to 80% of the cases are related to environmental factors and lifestyle, such as poor diet, sedentarism, obesity, smoking or excessive alcohol consumption. ...
May 8, 2025
0
35
Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to target and destroy cancer cells efficiently. One of the key challenges in immunotherapy is the uncertainty ...
May 8, 2025
0
0
A protein identified by researchers at UT Southwestern Medical Center may drive resistance to immune checkpoint inhibitors, a widely used form of immunotherapy to treat cancer. The findings, published in Communications Medicine, ...
May 8, 2025
0
0
A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published in Nature Cancer, may ...
May 8, 2025
0
0
